Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells

Biochemical and Biophysical Research Communications

Volumn 427, Issue 1, 2012, Pages 171-177

  Lee, Han Na ^a   Park, Soo Hyun ^a   Lee, Eun Kyung ^a   Bernardo, Raymundo ^a   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

Author keywords

Cancer stem cell; CD133; Colorectal cancer; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; CD133 ANTIGEN; PROFILIN;

ARTICLE; CANCER CELL; CANCER STEM CELL; CLONOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS;

ANTIGENS, CD; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; COLORECTAL NEOPLASMS; GLYCOPROTEINS; HT29 CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PEPTIDES; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867646822     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.036     Document Type: Article

References (43)

1. Thun M.J., Jemal A. How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking?. Tob. Control 2006, 15(5):345-347.
2. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
3. Ricci-Vitiani L., et al. Colon cancer stem cells. J. Mol. Med. (Berl) 2009, 87(11):1097-1104.
4. Ieta K., et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann. Surg. Oncol. 2008, 15(2):638-648.
5. Bhatia M. AC133 expression in human stem cells. Leukemia 2001, 15(11):1685-1688.
6. Maw M.A., et al. A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum. Mol. Genet. 2000, 9(1):27-34.
7. Miraglia S., et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90(12):5013-5021.
8. O'Brien C.A., et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445(7123):106-110.
9. Ricci-Vitiani L., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-115.
10. Singh S.K., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63(18):5821-5828.
11. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
12. Yin S., et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 2007, 120(7):1444-1450.
13. Lee E.K., et al. Transgelin promotes migration and invasion of cancer stem cells. J. Proteome Res. 2010, 9(10):5108-5117.
14. Lee E.K., Cho H., Kim C.W. Proteomic analysis of cancer stem cells in human prostate cancer cells. Biochem. Biophys. Res. Commun. 2011, 412(2):279-285.
15. Till J.E., McCulloch E.A., Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc. Natl. Acad. Sci. USA 1964, 51:29-36.
16. Cho C.W., et al. Improvement of the two-dimensional gel electrophoresis analysis for the proteome study of Halobacterium salinarum. Proteomics 2003, 3(12):2325-2329.
17. Lee S.H., et al. Proteomic characterization of rat liver exposed to 2,3,7,8-tetrachlorobenzo-p-dioxin. J. Proteome Res. 2005, 4(2):335-343.
18. Han G.Y., et al. Effects of vibration on the proteome expression of anterior cruciate ligament cells. Exp. Biol. Med. (Maywood) 2011, 236(7):783-789.
19. Kim H.J., et al. Comparative analysis of serum proteomes of patients with cardiovascular disease. Clin. Biochem. 2011, 44(2-3):178-184.
20. 2-induced premature senescent human mesenchymal stem cells. Exp. Gerontol. 2011, 46(6):500-510.
21. Park S.A., et al. Effects of Tau on the activity of triose phosphate isomerase (TPI) in brain cells. Neurochem. Int. 2010, 56(8):886-892.
22. Tirino V., et al. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 2008, 3(10):3469.
23. Ewing R.M., et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 2007, 3:89.
24. Yutin N., et al. The origins of phagocytosis and eukaryogenesis. Biol. Direct 2009, 4:9.
25. Pilo Boyl P., et al. Profilin2 contributes to synaptic vesicle exocytosis neuronal excitability and novelty-seeking behavior. EMBO J. 2007, 26(12):2991-3002.
26. Al-Hajj M., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100(7):3983-3988.
27. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 2004, 101(3):781-786.
28. Li C., et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67(3):1030-1037.
29. Ponti D., et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65(13):5506-5511.
30. Prince M.E., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104(3):973-978.
31. Richardson G.D., et al. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 2004, 117(16):3539-3545.
32. Suetsugu A., et al. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 2006, 351(4):820-824.
33. Goley E.D., Welch M.D. The ARP2/3 complex: an actin nucleator comes of age. Nat. Rev. Mol. Cell Biol. 2006, 7(10):713-726.
34. Machesky L.M., et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. Proc. Natl. Acad. Sci. USA 1999, 96(7):3739-3744.
35. Rohatgi R., et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 1999, 97(2):221-231.
36. Otsubo T., et al. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod. Pathol. 2004, 17(4):461-467.
37. Li F., et al. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007, 17(1):3-14.
38. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004, 14(8):461-469.
39. Witke W., et al. Profilin I is essential for cell survival and cell division in early mouse development. Proc. Natl. Acad. Sci. USA 2001, 98(7):3832-3836.
40. Gareus R., et al. Mouse profilin 2 regulates endocytosis and competes with SH3 ligand binding to dynamin 1. J. Biol. Chem. 2006, 281(5):2803-2811.
41. Lee Y., et al. Prefoldin 5 is required for normal sensory and neuronal development in a murine model. J. Biol. Chem. 2011, 286(1):726-736.
42. Fujioka Y., et al. MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. J. Biol. Chem. 2001, 276(48):45137-45144.
43. Sakono M., et al. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J. 2008, 275(23):5982-5993.